Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Cell Dyscrasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04364256
What this trial is testing

Muscle Stimulation for Physical Function During Stem Cell Transplant

Who this might be right for
Autologous Hematopoietic Stem Cell Transplant
VA Office of Research and Development 46
Post-approval studies (Phase 4)WithdrawnNCT05183139
What this trial is testing

In-class Transition Study of Ixazomib Combined With Pomalidomide and Dexamethasone or With Lenalidomide and Dexamethasone in Adults With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Takeda
Testing effectiveness (Phase 2)Active Not RecruitingNCT04933539
What this trial is testing

Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Study completedNCT03700450
What this trial is testing

Cyclophosphamide as Graft-versus-host Prophylaxis After Allogeneic Stem Cell Transplantation for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf 37
Not applicableUnknownNCT02184897
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study of Lenograstim for Hematopoietic Stem Cell Mobilization

Who this might be right for
Multiple Myeloma
Asan Medical Center 24
Large-scale testing (Phase 3)Study completedNCT02181413
What this trial is testing

Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant

Who this might be right for
Multiple MyelomaAutologous Stem Cell Transplant
Takeda 656
Not applicableNo Longer AvailableNCT00063791
What this trial is testing

Assess Two Different Strategies of Combining Dexamethasone and VELCADE

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)WithdrawnNCT00004040
What this trial is testing

Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell Neoplasm
Hoag Memorial Hospital Presbyterian
Testing effectiveness (Phase 2)Looking for participantsNCT04661137
What this trial is testing

Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hackensack Meridian Health 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT00869232
What this trial is testing

UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

Who this might be right for
Multiple Myeloma
University of Arkansas 90
Early research (Phase 1)Study completedNCT00060645
What this trial is testing

Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)

Who this might be right for
TumorsLymphomaMultiple Myeloma
Merck Sharp & Dohme LLC 33
Testing effectiveness (Phase 2)Study completedNCT00003572
What this trial is testing

Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Testing effectiveness (Phase 2)Study completedNCT01668719
What this trial is testing

S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma

Who this might be right for
DS Stage I Plasma Cell MyelomaDS Stage II Plasma Cell MyelomaDS Stage III Plasma Cell Myeloma
SWOG Cancer Research Network 142
Testing effectiveness (Phase 2)Study completedNCT01989598
What this trial is testing

Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
National Cancer Institute (NCI) 25
Not applicableStudy completedNCT05306587
What this trial is testing

Daratumumab Provided at Home Experience An Open, Single-center, Mixed-method Project.

Who this might be right for
Multiple Myeloma
Thomas Lund 40
Testing effectiveness (Phase 2)WithdrawnNCT03841565
What this trial is testing

Daratumumab, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell Myeloma
Academic and Community Cancer Research United
Testing effectiveness (Phase 2)Study completedNCT01160107
What this trial is testing

Revlimid And Prednisone Followed By Revlimid, Melphalan And Prednisone In Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 46
Not applicableStudy completedNCT01270009
What this trial is testing

Role of BCL-B in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Centre Hospitalier Universitaire de Nice 60
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Not applicableStudy completedNCT04236063
What this trial is testing

Rehabilitation Needs of the Malaysian Haematological Cancer Survivors

Who this might be right for
Haematological MalignancyLeukemia, AcuteLymphoma+3 more
University of Malaya 168
Next Page